• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

针对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)M受体的选定植物化学物质的分子对接分析。

Molecular docking analysis of selected phytochemicals against SARS-CoV-2 M receptor.

作者信息

Garg Saksham, Anand Ashutosh, Lamba Yash, Roy Arpita

机构信息

Department of Biotechnology, Delhi Technological University, Delhi, India.

Cluster Innovation Center, University of Delhi, Delhi, India.

出版信息

Vegetos. 2020;33(4):766-781. doi: 10.1007/s42535-020-00162-1. Epub 2020 Oct 16.

DOI:10.1007/s42535-020-00162-1
PMID:33100613
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7567421/
Abstract

Presently world is on a war with the novel coronavirus and with no immediate treatments available the scourge caused by the SARS-CoV-2 is increasing day by day. A lot of researches are going on for the potential drug candidate that could help the healthcare system in this fight. Plants are a natural data bank of bioactive compounds. Many phytochemicals are being studied for various ailments including cancer, bacterial and viral infections, etc. The present study aims to screen 38 bioactive compounds from 5 selected plants viz., , , , and against SARS-CoV-2. Lipinski's rule was taken as the foundation for initial screening. Shortlisted compounds were subjected to molecular docking study with M receptor present in SARS-CoV-2. The study identified that gedunin, epoxyazadiradione, nimbin and ginsenosides have potential to inhibit M activity and their binding energies are - 9.51 kcal/mol, - 8.47 kcal/mol, - 8.66 kcal/mol and - 9.63 kcal/mol respectively. Based on bioavailability radar studies gedunin and epoxyazadiradione are the two most potent compounds which are used for molecular dynamics simulation studies. Molecular dynamics studies showed that gedunin is more potent than epoxyazadiradione. To find the effectiveness and to propose the exact mechanism, in-vitro studies can be further performed on gedunin.

摘要

目前,世界正在与新型冠状病毒作斗争,由于没有立即可用的治疗方法,由严重急性呼吸综合征冠状病毒2(SARS-CoV-2)引起的灾难日益加剧。许多研究正在寻找潜在的候选药物,以帮助医疗系统进行这场战斗。植物是生物活性化合物的天然数据库。许多植物化学物质正在针对各种疾病进行研究,包括癌症、细菌和病毒感染等。本研究旨在从5种选定的植物中筛选38种生物活性化合物,即[此处原文缺失植物名称],以对抗SARS-CoV-2。以Lipinski规则为基础进行初步筛选。将入围的化合物与SARS-CoV-2中存在的M受体进行分子对接研究。研究发现,格杜宁、环氧印楝二酮、印楝素和人参皂苷有抑制M活性的潜力,它们的结合能分别为-9.51千卡/摩尔、-8.47千卡/摩尔、-8.66千卡/摩尔和-9.63千卡/摩尔。基于生物利用度雷达研究,格杜宁和环氧印楝二酮是两种最有效的化合物,用于分子动力学模拟研究。分子动力学研究表明,格杜宁比环氧印楝二酮更有效。为了确定其有效性并提出确切机制,可以对格杜宁进一步进行体外研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/31a3/7567421/fc458696012b/42535_2020_162_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/31a3/7567421/8909c9381b5e/42535_2020_162_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/31a3/7567421/a7c2a621de09/42535_2020_162_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/31a3/7567421/1a4df42af6bd/42535_2020_162_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/31a3/7567421/2cef88f07327/42535_2020_162_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/31a3/7567421/ccad2d2c4a60/42535_2020_162_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/31a3/7567421/2febd80e8978/42535_2020_162_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/31a3/7567421/db462d4db068/42535_2020_162_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/31a3/7567421/d88b5523efaa/42535_2020_162_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/31a3/7567421/fc458696012b/42535_2020_162_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/31a3/7567421/8909c9381b5e/42535_2020_162_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/31a3/7567421/a7c2a621de09/42535_2020_162_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/31a3/7567421/1a4df42af6bd/42535_2020_162_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/31a3/7567421/2cef88f07327/42535_2020_162_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/31a3/7567421/ccad2d2c4a60/42535_2020_162_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/31a3/7567421/2febd80e8978/42535_2020_162_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/31a3/7567421/db462d4db068/42535_2020_162_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/31a3/7567421/d88b5523efaa/42535_2020_162_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/31a3/7567421/fc458696012b/42535_2020_162_Fig9_HTML.jpg

相似文献

1
Molecular docking analysis of selected phytochemicals against SARS-CoV-2 M receptor.针对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)M受体的选定植物化学物质的分子对接分析。
Vegetos. 2020;33(4):766-781. doi: 10.1007/s42535-020-00162-1. Epub 2020 Oct 16.
2
Exploring Phytochemicals of Traditional Medicinal Plants Exhibiting Inhibitory Activity Against Main Protease, Spike Glycoprotein, RNA-dependent RNA Polymerase and Non-Structural Proteins of SARS-CoV-2 Through Virtual Screening.通过虚拟筛选探索对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的主要蛋白酶、刺突糖蛋白、RNA依赖性RNA聚合酶和非结构蛋白具有抑制活性的传统药用植物的植物化学物质。
Front Pharmacol. 2021 Jul 8;12:667704. doi: 10.3389/fphar.2021.667704. eCollection 2021.
3
Evaluation of bioactive compounds from against SARS-CoV-2.对来自……的生物活性化合物抗新型冠状病毒2的评估。 (原文中“from”后缺少具体内容)
Vegetos. 2022;35(2):404-414. doi: 10.1007/s42535-021-00318-7. Epub 2021 Nov 17.
4
Computational Evidences of Phytochemical Mediated Disruption of PLpro Driven Replication of SARS-CoV-2: A Therapeutic Approach against COVID-19.基于植物化学物的计算证据表明其可破坏 SARS-CoV-2 的 PLpro 驱动的复制:针对 COVID-19 的治疗方法。
Curr Pharm Biotechnol. 2021;22(10):1350-1359. doi: 10.2174/1389201021999201110204116.
5
Macrolactin A as a Novel Inhibitory Agent for SARS-CoV-2 M: Bioinformatics Approach.大环内酯素 A 作为新型 SARS-CoV-2 M 抑制剂:生物信息学方法。
Appl Biochem Biotechnol. 2021 Oct;193(10):3371-3394. doi: 10.1007/s12010-021-03608-7. Epub 2021 Jul 1.
6
Potential combination therapy using twenty phytochemicals from twenty plants to prevent SARS- CoV-2 infection: An in silico Approach.使用来自二十种植物的二十种植物化学物质预防新型冠状病毒感染的潜在联合疗法:一种计算机模拟方法。
Virusdisease. 2021 Mar;32(1):108-116. doi: 10.1007/s13337-021-00658-7. Epub 2021 Apr 5.
7
Silybin B and Cianidanol Inhibit M and Spike Protein of SARS-CoV-2: Evidence from in silico Molecular Docking Studies.水飞蓟宾B和奇尼丹醇抑制新型冠状病毒的M蛋白和刺突蛋白:基于计算机模拟分子对接研究的证据
Curr Pharm Des. 2021;27(32):3476-3489. doi: 10.2174/1381612826666201210122726.
8
study of potential SARS-CoV-2 antagonist from .来自……的新型严重急性呼吸综合征冠状病毒2拮抗剂的研究 (你提供的原文不完整,“from”后面缺少具体内容)
Int J Health Sci (Qassim). 2023 May-Jun;17(3):3-10.
9
Identification of Novel Phyto-chemicals from Ocimum basilicum for the Treatment of Parkinson's Disease using In Silico Approach.利用计算机模拟方法从罗勒中鉴定治疗帕金森病的新型植物化学物质。
Curr Comput Aided Drug Des. 2020;16(4):420-434. doi: 10.2174/1573409915666190503113617.
10
Screening marine algae metabolites as high-affinity inhibitors of SARS-CoV-2 main protease (3CLpro): an in silico analysis to identify novel drug candidates to combat COVID-19 pandemic.筛选海洋藻类代谢产物作为严重急性呼吸综合征冠状病毒2主蛋白酶(3CLpro)的高亲和力抑制剂:一项计算机模拟分析,以确定对抗新冠疫情的新型候选药物。
Appl Biol Chem. 2020;63(1):79. doi: 10.1186/s13765-020-00564-4. Epub 2020 Nov 21.

引用本文的文献

1
An In Vivo and In Silico Approach Reveals Possible Sodium Channel Nav1.2 Inhibitors from as a Novel Treatment for Epilepsy.体内和计算机模拟方法揭示了来自[具体来源未给出]的可能的钠通道Nav1.2抑制剂作为癫痫的一种新疗法。
Brain Sci. 2024 May 27;14(6):545. doi: 10.3390/brainsci14060545.
2
From Flora to Pharmaceuticals: 100 new additions to angiosperms of Gafargaon subdistrict in Bangladesh and unraveling antidiabetic drug candidates targeting DPP4 through in silico approach.从植物群到制药:孟加拉国加富尔甘区新增 100 种被子植物和通过计算机模拟方法发现针对 DPP4 的抗糖尿病药物候选物。
PLoS One. 2024 Mar 29;19(3):e0301348. doi: 10.1371/journal.pone.0301348. eCollection 2024.
3

本文引用的文献

1
COVID-19: immunopathogenesis and Immunotherapeutics.新型冠状病毒肺炎:免疫发病机制与免疫治疗。
Signal Transduct Target Ther. 2020 Jul 25;5(1):128. doi: 10.1038/s41392-020-00243-2.
2
In Silico Screening of Potential Chinese Herbal Medicine Against COVID-19 by Targeting SARS-CoV-2 3CLpro and Angiotensin Converting Enzyme II Using Molecular Docking.基于分子对接的针对 SARS-CoV-2 3CLpro 和血管紧张素转化酶 II 的新冠病毒潜在中草药的计算机筛选
Chin J Integr Med. 2020 Jul;26(7):527-532. doi: 10.1007/s11655-020-3476-x. Epub 2020 Jul 6.
3
Anti-viral activity of (Ginger) ingredients against the Chikungunya virus.
Design, Synthesis, and Biological Evaluation of Novel Coumarin Analogs Targeted against SARS-CoV-2.
新型针对 SARS-CoV-2 的香豆素类似物的设计、合成与生物评价。
Molecules. 2024 Mar 21;29(6):1406. doi: 10.3390/molecules29061406.
4
In Silico Approaches to Developing Novel Glycogen Synthase Kinase 3β (GSK-3β).开发新型糖原合酶激酶3β(GSK-3β)的计算机模拟方法
Biomedicines. 2023 Oct 13;11(10):2784. doi: 10.3390/biomedicines11102784.
5
In-silico docking studies of selected phytochemicals against papain like protease of SARS-Cov-2.对选定植物化学物质针对新型冠状病毒2型(SARS-CoV-2)木瓜蛋白酶样蛋白酶的计算机对接研究。
Vegetos. 2023;36(1):188-194. doi: 10.1007/s42535-022-00525-w. Epub 2022 Dec 6.
6
In Silico Approach for the Evaluation of the Potential Antiviral Activity of Extra Virgin Olive Oil (EVOO) Bioactive Constituents Oleuropein and Oleocanthal on Spike Therapeutic Drug Target of SARS-CoV-2.基于计算机的方法评估特级初榨橄榄油(EVOO)生物活性成分橄榄苦苷和油橄榄苦苷对 SARS-CoV-2 刺突治疗药物靶点的潜在抗病毒活性。
Molecules. 2022 Nov 4;27(21):7572. doi: 10.3390/molecules27217572.
7
Synthesis, biological evaluation and molecular docking of new triphenylamine-linked pyridine, thiazole and pyrazole analogues as anticancer agents.新型三苯胺连接的吡啶、噻唑和吡唑类似物作为抗癌剂的合成、生物学评价及分子对接
BMC Chem. 2022 Nov 7;16(1):88. doi: 10.1186/s13065-022-00879-x.
8
Molecular Docking, Validation, Dynamics Simulations, and Pharmacokinetic Prediction of Phytochemicals Isolated From Against the HIV-1 Reverse Transcriptase.从[具体来源未给出]中分离出的植物化学物质对HIV-1逆转录酶的分子对接、验证、动力学模拟和药代动力学预测
Bioinform Biol Insights. 2022 Sep 26;16:11779322221125605. doi: 10.1177/11779322221125605. eCollection 2022.
9
Potential of as a Capping Agent for Antiviral Nanoparticles against SARS-CoV-2.作为一种用于抗病毒纳米粒子对抗 SARS-CoV-2 的盖帽试剂的潜力。
Biomed Res Int. 2022 Sep 15;2022:5714035. doi: 10.1155/2022/5714035. eCollection 2022.
10
Design and synthesis of novel enantiopure Bis(5-Isoxazolidine) derivatives: insights into their antioxidant and antimicrobial potential via in silico drug-likeness, pharmacokinetic, medicinal chemistry properties, and molecular docking studies.新型对映体纯双(5-异恶唑烷)衍生物的设计与合成:通过计算机辅助药物相似性、药代动力学、药物化学性质及分子对接研究洞察其抗氧化和抗菌潜力
Heliyon. 2022 Jun 24;8(6):e09746. doi: 10.1016/j.heliyon.2022.e09746. eCollection 2022 Jun.
(生姜)成分对基孔肯雅病毒的抗病毒活性。
Virusdisease. 2020 Sep;31(3):270-276. doi: 10.1007/s13337-020-00584-0. Epub 2020 May 5.
4
Structural elucidation of SARS-CoV-2 vital proteins: Computational methods reveal potential drug candidates against main protease, Nsp12 polymerase and Nsp13 helicase.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)关键蛋白的结构解析:计算方法揭示了针对主要蛋白酶、Nsp12聚合酶和Nsp13解旋酶的潜在候选药物。
J Pharm Anal. 2020 Aug;10(4):320-328. doi: 10.1016/j.jpha.2020.04.008. Epub 2020 Apr 28.
5
Structure of M from SARS-CoV-2 and discovery of its inhibitors.SARS-CoV-2 M 结构与抑制剂的发现
Nature. 2020 Jun;582(7811):289-293. doi: 10.1038/s41586-020-2223-y. Epub 2020 Apr 9.
6
Pathogenicity and transmissibility of 2019-nCoV-A quick overview and comparison with other emerging viruses.2019-nCoV 的致病性和传染性:快速概述及与其他新兴病毒的比较
Microbes Infect. 2020 Mar;22(2):69-71. doi: 10.1016/j.micinf.2020.01.004. Epub 2020 Feb 4.
7
Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.《武汉 2019 年新型冠状病毒感染的肺炎 138 例住院患者临床特征分析》
JAMA. 2020 Mar 17;323(11):1061-1069. doi: 10.1001/jama.2020.1585.
8
A new coronavirus associated with human respiratory disease in China.一种在中国与人类呼吸道疾病相关的新型冠状病毒。
Nature. 2020 Mar;579(7798):265-269. doi: 10.1038/s41586-020-2008-3. Epub 2020 Feb 3.
9
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.中国武汉地区 2019 年新型冠状病毒感染患者的临床特征。
Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24.
10
Antiviral activity of five Asian medicinal pant crude extracts against highly pathogenic H5N1 avian influenza virus.五种亚洲药用植物粗提物对高致病性H5N1禽流感病毒的抗病毒活性
Asian Pac J Trop Med. 2017 Sep;10(9):871-876. doi: 10.1016/j.apjtm.2017.08.010. Epub 2017 Sep 14.